|
|
Title | Creator | Relation Is Part Of |
1 |
|
MS Treatment/Immune System Targets | Robert Shin, MD | NANOS Annual Meeting 2023: Neuroimmunology: https://novel.utah.edu/collection/NAM/toc/ |
2 |
|
Decreased Vision in Multiple Sclerosis is Associated With Novel Foveal Features Visualized Using Adaptive Optics | Aubrey C. Hargrave, Lakshmi Leishangthem, May Han, Lucas Kipp, Fareshta Khushzad, Jennifer Yarp, Nripun Sredar, Alfredo Dubra, Heather Moss | NANOS Annual Meeting 2021: Scientific Platform I |
3 |
|
Therapies for Multiple Sclerosis | Sashank Prasad, MD, Brigham and Women's Hospital | NANOS 2013: Jorunal Club |
4 |
|
Color Vision Deficits in Multiple Sclerosis (Video) | Neda Ansari; Reza Vosoughi; Kathleen T. Mullen; Ambarish Pandey; Behzad Mansouri | NANOS Annual Meeting 2015 Scientific Platform Presentations (Session 1) |
5 |
|
The Eye-Brain Interface in Cerebral Malaria (video) | Douglas Postels, MD, MS | NANOS Annual Meeting 2016: Hot Topics - Today and Tomorrow |
6 |
|
MS and the Immune System | Jennifer Graves, MD, PhD, MAS | NANOS Annual Meeting 2023: Neuroimmunology: https://novel.utah.edu/collection/NAM/toc/ |
7 |
|
We Can Hardly Believe Our Eyes | Andrew Dugue, Scott Grossman, Nicolas Abreu, Steven Galetta, Lauren Krupp, Marc Branche, Janet Rucker, Laura Balcer, Claire Miller, Christopher William, Kimberly O'Neill | NANOS Annual Meeting 2023: Walsh Society Meeting Session I: "Adventureland": Learning From Pediatric Neuro-Ophthalmic Disorders: https://novel.utah.edu/collection/NAM/toc/ |
8 |
|
Patient-Reported Outcome Measures in Neuro-Ophthalmic Clinical Research | Lindsey De Lott, MD, MS | NANOS Annual Meeting 2022: Hot Topics |
9 |
|
Classification of Functional Disorders and Role of Modern Neuroimaging | Jeffrey P. Staab, MD, MS | NANOS Annual Meeting 2022: Functional Disorders and the Neuro-Ophthalmologist |
10 |
|
The Impact of Acetylcholine Receptor Antibody Titers in Acetylcholine Receptor Antibody-Positive Ocular Myasthenia Gravis: Generalization, Presence of Thyroid Autoimmune Antibodies, and Thymoma | Montana Supawongwattana; Kavin Vanikieti; Panitha Jindahra; Tanyatuth Padungkiatsagul | NANOS Annual Meeting 2023: Scientific Platform Session I: https://novel.utah.edu/collection/NAM/toc/ |
11 |
|
New Therapies for Multiple Sclerosis, Beyond the ABCs | Ari J. Green | NANOS Annual Meeting Journal Club, 2015 |
12 |
|
New Therapies for Multiple Sclerosis, Beyond the ABCs (video) | Ari J. Green, MD, University of California San Francisco | NANOS Annual Meeting Journal Club, 2015 |
13 |
|
Characterization of Subclinical Optic Nerve MRI Lesions in the N-Momentum Trial | Jeffrey Bennett; Friedemann Paul; John Chen; Michael Smith; Daniel Cimbora; Kristina Patterson; Bruce Cree | NANOS Annual Meeting 2023: Scientific Platform Session III: https://novel.utah.edu/collection/NAM/toc/ |
14 |
|
Double Vision, Double Again | Virender Sachdeva, MS, DNB | NANOS Annual Meeting 2022: Complex Cases in Pediatric Neuro-Ophthalmology: Avoiding Mimickers, Missteps, and Misdiagnosis |
15 |
|
Genotype-Phenotype Correlations in Autosomal Dominant Optic Atrophy | Joshua Harvey, MA, BM, BCh, FRCOphth | NANOS Annual Meeting 2022: Scientific Platform III |
16 |
|
Leber's Hereditary Optic Neuropathy in Women | Giulia Amore, Martina Romagnoli, Chiara La Morgia, Michele Carbonelli, Francesca Allegrini, Rustum Karanjia, Alfredo Sadun, Valerio Carell | NANOS Annual Meeting 2021: Scientific Platform Session II |
17 |
|
A Randomized Prospective Trial Comparing Repository Corticotropin Injection and Intravenous Methylprednisolone in Acute Optic Neuritis | Jeffrey Bennett, MD | NANOS Annual Meeting 2022: Scientific Platform Session II |
18 |
|
Sustainability of Teprotumumab Efficacy in Thyroid Eye Disease | Prem S. Subramanian, Saba Sile, Robert Holt, Raymond Douglas | NANOS Annual Meeting 2022: Scientific Platform III |
19 |
|
Continuous Hypoxia Reduces Retinal Ganglion Cell Degeneration in a Mouse Model of Mitochondrial Optic Neuropathy | Sidney Gospe, MD, PhD | NANOS Annual Meeting 2022: Scientific Platform III |
20 |
|
In Vivo Application of Electric Fields Collaborate With rRHEB to Direct Optic Nerve Regeneration | Timothy Kim; Sasha Medvidovic; Phillip Lam; Petcy Yao; Ege Iseri; Micalla Peng; Biju Thomas; Mahnaz Shahidi; Gianluca Lazzi; Kimberly Gokoffski | NANOS Annual Meeting 2023: Scientific Platform Session II: https://novel.utah.edu/collection/NAM/toc/ |
21 |
|
Long-Term Efficacy of Satralizumab in Neuromyelitis Optica Spectrum Disorder: Results from SAkuraSky and SAkuraStar | Benjamin M. Greenberg, Jerome de Seze, Albert Saiz, Takashi Yamamura, Michael Yeamen, Carole Marcillat, Xiujing Kou, Kristina Weber, Kathleen Blondeau, Brian Weinshenker, Francesco Patti | NANOS Annual Meeting 2022: Scientific Platform Session II |
22 |
|
Teprotumumab Efficacy in Retreatment and Longer-Term Thyroid Eye Disease: OPTIC-X Study Results | Raymond Douglas, Saba Sile, Terry Smith, George Kahaly | NANOS Annual Meeting 2021: Scientific Platform I |
23 |
|
VRDN-001, a Full Antagonist Antibody to IGF-1 Receptor for Thyroid Eye Disease (TED): Phase 1/2 Clinical Study in Patients | Raymond Douglas; Kimberley Cockerham; Roger Turbin; Rosa Tang; Navdeep Nijhawan Shoaib Ugradar; Denis O'Shaughnessy; Rochelle Summerfelt; Angela She; Barrett Katz | NANOS Annual Meeting 2023: Scientific Platform Session II: https://novel.utah.edu/collection/NAM/toc/ |
24 |
|
Epigenetic Reprogramming- A Novel Gene Therapy to Rejuvenate Injury-Induced Dysfunction of Retinal Ganglion Cells in Optic Neuropathies | Drenushe Krasniqi; Madhura Shah; Margarete Karg; Yuancheng Lu; David Sinclair; Bruce Ksander; Joseph Rizzo | NANOS Annual Meeting 2023: Scientific Platform Session II: https://novel.utah.edu/collection/NAM/toc/ |
25 |
|
European Perspective - It Could Be MS | Axel Petzold, MD, PhD, FRCP, FRCPath, FRCOphth | NANOS Annual Meeting 2023: State of the Art - Global Perspectives: https://novel.utah.edu/collection/NAM/toc/ |